Zephyr Health Announces Real World Evidence Initiative at EyeForPharma Conference, Amsterdam

Leading Insights-as-a-Service Company Invites Life Science Companies to Experience the Potential of Real World Evidence to Improve Product Life Cycle Success

AMSTERDAM, June 3, 2015 – Today at EyeforPharma, Real World Evidence in Amsterdam, the Netherlands, Zephyr Health, the insights-as-a-service company for Life Sciences, announced the launch of its Real World data initiative using statistics on diabetes in England as the basis for demonstrating how patient outcomes can add value to commercial strategies.

Sera Prognostics Closes $20 Million in Series B Financing

Mansoor Raza Mirza, MD Appointed to Board of Directors

SALT LAKE CITY, January 7, 2015--Sera Prognostics, Inc., a women’s healthcare company, today announced that it has closed $20 Million in Series B financing. Leading the Series B investment is Chione, Ltd, a European investment company supporting the development of medical diagnostic, pharmaceutical and IT technologies world-wide.